Latest News
US close: Stocks tumble following heavy tech selloff
Wall Street indices tumbled on Thursday as tech stocks snapped a ten-day winning streak.
US court of appeals upholds ruling in favour of Hikma over Vascepa
US courts ruled against an appeal by Amarin related to Hikma Pharmaceuticals's generic treatment for heart conditions, Vascepa.
Sector movers: Miners, Homebuilders pace losses as sentiment shifts a tad
Miners and Homebuilders paced fallers in the stockmarket on Thursday with a slightly worse-than-expected reading on initial weekly jobless claims acting as the apparent trigger for the selling.
Europe close: Stocks end lower as investors in technology space
A slightly worse than expected reading on weekly US jobs filings triggered profit-taking took stocks in Europe down a peg.
London close: Stocks turn lower on fresh vaccine jitters
London stocks had turned lower by the close on Thursday, as investors mulled over the latest reading on the UK services sector.
Director dealings: Balfour Beatty boss picks up some shares
Balfour Beatty revealed on Thursday that chief executive Leo Quinn had acquired 226,127 ordinary shares in the FTSE 250-listed builder.
Friday preview: US non-farm payrolls, Berkeley Group Holdings in the spotlight
The focus in markets will be squarely on the US non-farm payrolls report for August.
IQGeo wins 'significant' new tier 1 telecoms contract
IQGeo announced a “significant” new contract for software licenses and services with a large tier 1 telecoms network operator on Thursday.
Broker tips: Barratt Developments, Next, Johnson Service Group
Analysts at Canaccord Genuity nudged up their target price on residential property developer Barratt Developments from 625. 0p to 630. 0p on Thursday, stating the group's planned volume growth supported profit recovery.
US trade deficit for July jumps past forecasts
America's shortfall on trade in goods and services with the rest of the world widened in July as import growth outpaced that of exports.
FTSE 250 movers: Travel stocks rally; Hammerson heads lower
London’s FTSE 250 was down 0. 5% at 17,613. 38 in afternoon trade on Thursday.
Xiaomi backs Dreame in $15m funding round
Smartphone maker Xiaomi backed Chinese vacuum company Dreame in a $15m funding round as part of its expansion into the consumer electronics arena.
US open: Stocks slide following yesterday's record breaking rally
Wall Street stocks were lower after the opening bell on Thursday following yesterday's strong session, with tech stocks taking the biggest hit in early trading.
US jobless claims fall as calculation method changes
US jobless claims fell below 1m to the lowest since Covid-19 lockdowns began as the method for calculating official figures changed.
Thursday broker round-up
CMC Markets: Peel Hunt upgrades to buy with a target price of 380. 0p.
US services sector activity cools a little in August
The pace of services sector activity in the States ebbed a bit last month, as the rate of incoming new orders slowed, the results of a closely-watched survey showed.
Allergy Therapeutics signs new vaccine deal with Saliba and DeepVax
Biotechnology company Allergy Therapeutics announced further investment in virus-like particle (VLP) technology for applications beyond the allergy immunotherapy field on Thursday.
7digital announces fundraise of at least £5m
Digital music company 7digital Group intends to raise at least £5m, it announced on Thursday, to support a number of commercial growth opportunities.
FTSE 100 movers: Melrose Industries rallies; Next hit by downgrade
London’s FTSE 100 was up 0. 2% at 5,951. 38 in afternoon trade on Thursday.
Morgan Stanley downgrades rating on 'very overvalued' Next shares
Morgan Stanley downgraded its rating on shares of Next on Thursday to ‘underweight’ from ‘equalweight’ arguing that the stock is "very overvalued", currently trading higher than it was a year ago, which it said "makes very little sense" given it’s been hit hard by the Covid-19 pandemic.
Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.